S. B. Raikar, P. Nuhant, B. Delpech, C. Marazano
FULL PAPER
as a viscous light-yellow oil which solidified upon standing. An
analytical sample was obtained by recrystallization from heptane/
EtOAc (80:20); m.p. 104–106 °C (ref.[24] 107–109 °C, recrystallized
(C-19), 139.0 (C-24), 173.9 (C-1), 188.7 (C-5), 194.0 (C-3), 196.0
(C-27) ppm. HRMS (ESI): calcd. for C33H42NaO4 [M + Na]+
525.2981; found 525.2956.
from ethanol/water). FTIR: ν = 3300, 2920, 1644, 1587, 1556, 1510,
˜
3,5-Dimethoxy-4-[5-methyl-2-(propan-2-ylidene)hex-4-enyl]-2,4-
bis(3-methylbut-2-enyl)-6-(phenylcarbonyl)cyclohexa-2,5-dienone:
K2CO3 (48 mg, 348 µmol) followed by Me2SO4 (22 µL, 231 µmol)
were added to a solution of 19c (27 mg, 54 µmol) in acetone
(1 mL). The mixture was stirred for 18 h at room temp., diluted
with EtOAc, washed with water and brine, dried with Na2SO4
and concentrated in vacuo. The residue was purified by flash
chromatography (heptane/EtOAc, 90:10) to yield the bis(methyl
enol ether) (17 mg, 60%) as a viscous light-yellow oil which was
also found to be composed of an inseparable mixture of regioiso-
1
1493, 1446, 1374, 1217, 1185, 1152, 1099, 796, 694 cm–1. H NMR
(300 MHz, C6D6): δ = 1.51 (s, 3 H, 14-H), 1.54 (s, 9 H, 15-H, 20-
H, 25-H), 1.57 (s, 3 H, 21-H), 1.61 (s, 3 H, 26-H), 1.63 (s, 3 H, 16-
H), 1.91–2.02 (m, 2 H, 10-H), 2.02–2.15 (m, 2 H, 11-H), 2.51–2.67
(m, 1 H, 7-H), 2.72–3.03 (m, 3 H, 7-H, 17-H), 3.23 (d, J = 7.6 Hz,
2 H, 22-H), 5.11 (t, J = 7.6 Hz, 1 H, 12-H), 5.19 (t, J = 7.0 Hz, 2
H, 8-H, 18-H), 5.26 (t, J = 7.1 Hz, 1 H, 23-H), 7.05–7.23 (m, 3 H,
30-H, 31-H 32-H), 7.61–7.76 (m, 2 H, 29-H, 33-H) ppm. 1H NMR
(300 MHz, CDCl3): δ = 1.51–1.85 (m, 21 H, 14-H, 15-H, 16-H, 20-
H, 21-H, 25-H, 26-H), 1.87–2.07 (m, 4 H, 10-H, 11-H), 2.43–2.82
(m, 4 H, 7-H, 17-H), 3.14 (minor tautomer) and 3.23 (major tauto-
mer) (d, J = 6.8 Hz, 2 H, 22-H), 4.81–5.24 (m, 4 H, 8-H, 12-H, 18-
H, 23-H), 7.30–7.56 (m, 5 H, Ar-H) ppm. 13C NMR (75 MHz,
C6D6): δ = 17.3 (C-16), 18.4 (C-20, C-25), 18.8 (C-14), 22.1 (C-22),
26.4 (C-21, C-26), 26.6 (C-15), 27.6 (C-11), 38.1 (C-7), 38.4 (C-17),
40.8 (C-10), 58.2 (C-2), 109.1 (C-4), 111.6 (C-6), 119.5 (C-8), 119.8
(C-18), 122.4 (C-23), 125.1 (C-12), 128.3 (C-29, C-33), 129.0 (C-30,
C-32), 129.4 (C-31), 131.6 (C-28), 132.2 (C-13), 135.7 (C-19), 139.6
(C-24), 140.1 (C-9), 173.7 (C-1), 190.2 (C-5), 195.0 (C-3), 197.1 (C-
27) ppm. 13C NMR (75 MHz, CDCl3): δ = 16.4 (C-16), 17.6 (C-
20), 17.9 (C-25), 18.0 (C-14), 21.1 (C-22), 25.6 (C-21), 25.8 (C-26),
25.9 (C-15), 26.6 (C-11), 37.1 (C-7), 37.3 (C-17), 39.8 (C-10), 57.2
(C-2), 107.8 (C-4), 109.7 (C-6), 118.1 (C-8), 118.4 (C-18), 120.9 (C-
23), 123.9 (C-12), 127.5 (C-29, C-33), 127.7 (C-30, C-32), 128.4 (C-
31), 130.1 (C-28), 130.8 (C-13), 134.9 (C-19), 136.7 (C-24), 138.8
(C-9), 173.4 (C-1), 188.6 (C-5), 194.5 (C-3), 196.0 (C-27) ppm.
HRMS (ESI): calcd. for C33H42NaO4 [M + Na]+ 525.2981; found
525.2987.
mers, the major form being characterized as follows. FTIR: ν =
˜
2921, 1744, 1673, 1647, 1598, 1449, 1259, 1222, 1090, 1023,
708 cm–1. 1H NMR (300 MHz, CDCl3): δ = 1.46–1.97 (m, 24 H,
12-H, 13-H, 15-H, 16-H, 20-H, 21-H, 25-H, 26-H), 2.47–2.48 (m,
6 H, 7-H, 9-H, 17-H), 2.99–3.33 (m, 2 H, 22-H), 3.55 (s, 3 H, 34-
H), 3.95 (s, 3 H, 35-H), 4.80–5.17 (m, 3 H, 10-H, 18-H, 23-H),
7.31–7.61 (m, 3 H, 30-H, 31-H, 32-H), 7.75–8.00 (m, 2 H, 29-H,
33-H) ppm. 13C NMR (75 MHz, CDCl3): δ = 17.8, 18.0, 18.1 (C-
12, C-20, C-25), 20.8 (C-15 or C-16), 21.0 (C16 or C-15), 22.9 (C-
22), 25.7, 25.9, 26.0 (C-13, C-21, C-26), 31.3 (C-9), 35.9 (C-7 or C-
17), 40.1 (C-17 or C-7), 53.9 (C-34), 59.1 (C-2), 61.4 (C-35), 89.0
(C-4)*, 104.9 (C-6)*, 118.8 (C-23), 122.7 (C-18), 123.6 (C-10), 128.1
(C-8), 128.4 (C-29, C-33), 129.1 (C-30, C-32), 129.3 (C-31), 130.1
(C-14), 131.3 (C-11), 132.9 (C-28), 134.5 (C-19), 138.6 (C-24), 169.5
(C-1), 170.7 (C-3), 187.9 (C-5), 196.3 (C-27) ppm; * deduced from
HMQC/HMBC experiments. HRMS (ESI): calcd. for C35H46NaO4
[M + Na]+ 553.3294; found 553.3314.
Electrophilic Cyclization Reactions: SnCl4 (53 µL, 0.44 mmol) was
slowly added to a solution of 13a (98 mg, 0.30 mmol) in CH2Cl2
(4 mL) at –10 °C. The mixture was stirred for 3 h at –10 °C, diluted
with CH2Cl2 (10 mL) and quenched with water. The aqueous phase
was extracted with CH2Cl2 and the organic layers were washed with
brine, dried with Na2SO4 and concentrated to give a yellow oil.
Purification by flash chromatography (heptane/EtOAc, 70:30) gave
20 (9 mg, 9%) and 21 (12 mg, 12%) as yellow oils.
3,5-Dihydroxy-4-[5-methyl-2-(propan-2-ylidene)hex-4-enyl]-2,4-
bis(3-methylbut-2-enyl)-6-(phenylcarbonyl)cyclohexa-2,5-dienone
(19c): The experiment was performed, starting from 16c, using the
same procedure as that described for the preparation of 19b to
afford 19c (58%) as a viscous light-yellow oil. Compound 19c was
found to be composed of an inseparable mixture of tautomeric
forms. The major tautomer was characterized as described below.
FTIR: ν = 3421, 2921, 1691, 1601, 1584, 1449, 1374, 1242, 1092,
˜
2,2-Dimethyl-6,6-bis(3-methylbut-2-enyl)-3,4-dihydro-2H-chromen-
1
1067, 709 cm–1. H NMR (300 MHz, C6D6): δ = 1.46–1.74 (m, 24
5,7(6H,8H)-dione (20): FTIR: ν = 3021, 2915, 1718, 1651, 1624,
˜
H, 12-H, 13-H, 15-H, 16-H, 20-H, 21-H, 25-H, 26-H), 2.57–3.06
(m, 6 H, 7-H, 9-H, 17-H), 3.27 (d, J = 6.6 Hz, 1 H, 22-H), 3.39–
3.48 (m, 1 H, 22-H), 4.99–5.39 (m, 3 H, 10-H, 18-H, 23-H), 7.01–
7.26 (m, 3 H, 30-H, 31-H, 32-H), 7.61–7.72 (m, 2 H, 29-H, 33-
H) ppm. 1H NMR (300 MHz, CDCl3): δ = 1.51–1.70 (m, 18 H, 12-
H, 13-H, 15-H or 16-H, 20-H, 21-H, 25-H), 1.74–1.86 (m, 6 H, 16-
H or 15-H, 26-H), 2.46–2.91 (m, 6 H, 7-H, 9-H, 17-H), 3.08–3.35
(m, 2 H, 22-H), 4.80–4.97 (m, 2 H, 10-H, 18-H), 5.11–5.23 (m, 1
H, 23-H), 7.31–7.66 (m, 5 H, Ar-H) ppm. 13C NMR (75 MHz,
C6D6): δ = 17.6, 17.9, 18.1 (C-12, C-20, C-25), 20.4 (C-15 or C-
16), 20.9 (C-16 or C-15), 21.5 (C-22), 25.7, 25.9 (C-13, C-21, C-
26), 28.1 (C-9), 30.2 (C-7 or C-17), 37.9 (C-17 or C-7), 57.3 (C-2),
108.6 (C-4), 110.8 (C-6), 118.5 (C-23), 119.3 (C-18), 121.6 (C-10),
123.9 (C-8), 128.5 (C-31), 128.6 (C-29, C-33), 130.4 (C-30, C-32),
1386, 1114 cm–1. 1H NMR (300 MHz, CDCl3): δ = 1.31 (s, 6 H,
20-H, 21-H), 1.57 (s, 6 H, 10-H, 15-H), 1.60 (s, 6 H, 11-H, 16-H),
1.73 (t, J = 6.5 Hz, 2 H, 18-H), 2.34 (tt, J = 6.5, 2.0 Hz, 2 H, 17-
H), 2.51 (d, J = 7.5 Hz, 4 H, 7-H, 12-H), 3.10 (t, J = 2.0 Hz, 2 H,
4-H), 4.83 (br. t, J = 7.5 Hz, 2 H, 8-H, 13-H) ppm. 13C NMR
(75 MHz, CDCl3): δ = 16.3 (C-17), 17.8 (C-10, C-15), 25.9 (C-11,
C-16), 26.4 (C-20, C-21), 32.1 (C-18), 35.9 (C-7, C-12), 43.3 (C-4),
64.6 (C-2), 78.3 (C-19), 111.5 (C-6), 118.7 (C-8, C-13), 134.9 (C-9,
C-14), 164.1 (C-5), 197.6 (C-1), 207.3 (C-3) ppm. HRMS (ESI):
calcd. for C21H30NaO3 [M + Na]+ 353.2093; found 353.2140.
2,2-Dimethyl-8,8-bis(3-methylbut-2-enyl)-3,4-dihydro-2H-chromen-
5,7(6H,8H)-dione (21): FTIR: ν = 2972, 2916, 1654, 1590, 1155,
˜
1115 cm–1. 1H NMR (300 MHz, CDCl3): δ = 1.32 (s, 6 H, 20-H,
131.9 (C-14), 133.4 (C-28), 134.6 (C-11), 136.0 (C-19), 139.1 (C- 21-H), 1.57 (s, 6 H, 10-H, 15-H), 1.60 (s, 6 H, 11-H, 16-H), 1.67
24), 173.2 (C-1), 189.6 (C-5), 193.5 (C-3), 196.1 (C-27) ppm. 13C
(t, J = 6.5 Hz, 2 H, 18-H), 2.40 (t, J = 6.5 Hz, 2 H, 17-H), 2.43
NMR (75 MHz, CDCl3): δ = 17.8, 18.0 (C-12, C-20, C-25), 20.8 (dd, J = 14.0, 7.0 Hz, 2 H, 7-HB, 12-HB), 2.62 (dd, J = 14.0, 7.0 Hz,
(C-15 or C-16), 21.2 (C-16 or C-15), 21.3 (C-22), 25.6, 25.8, 25.9 2 H, 7-HA, 12-HA), 3.24 (s, 2 H, 4-H), 4.82 (br. t, J = 7.0 Hz, 2 H,
(C-13, C-21, C-26), 31.3 (C-9), 38.2 (C-7 or C-17), 41.6 (C-17 or
C-7), 57.0 (C-2), 107.5 (C-4), 109.5 (C-6), 118.4 (C-23), 120.8 (C-
8-H, 13-H) ppm. 13C NMR (75 MHz, CDCl3): δ = 16.3 (C-17),
17.9 (C-10, C-15), 25.9 (C-11, C-16), 26.5 (C-20, C-21), 31.7 (C-
18), 123.1 (C-10), 127.4 (C-8), 127.7 (C-31), 128.4 (C-29, C-33), 18), 35.7 (C-7, C-12), 52.5 (C-4), 58.2 (C-2), 78.3 (C-19), 112.6 (C-
130.6 (C-30, C-32), 131.4 (C-14), 133.6 (C-28), 134.9 (C-11), 136.8 6), 118.3 (C-8, C-13), 135.2 (C-9, C-14), 170.4 (C-1), 191.4 (C-5),
1366
www.eurjoc.org
© 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2008, 1358–1369